XENE EPS Estimates
Xenon Pharmaceuticals Inc.
$34.33
+$0.43(+1.27%)
24
Overall
--
Value
9
Tech
39
Quality
Market Cap
$3.28B
Volume
1.62M
52W Range
$35.06 - $72.66
Target Price
$71.66
XENE EPS estimates: the consensus estimate for Xenon Pharmaceuticals Inc.'s current fiscal year is -$4.70 per share. Quarterly and next-year EPS forecasts, growth estimates and revenue projections follow.
XENE EPS Estimates
- EPS estimate, current quarter
- $-1.17
- EPS estimate, next quarter
- $-1.16
- EPS estimate, current year
- $-4.70
- EPS estimate, next year
- $-4.95
- EPS growth, 3-year
- -28.39%
| Fiscal year | EPS |
|---|---|
| 2025 | $-4.36 |
| 2024 | $-3.01 |
| 2023 | $-2.73 |
| 2022 | $-2.06 |
| 2021 | $-1.77 |
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | XENE | $34.33 | +1.3% | 1.62M |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |
Get Xenon Pharmaceuticals Inc. Data in Excel
Stream real-time data directly to your spreadsheets
BUY NOW